Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli.
Generation of inflammatory mediators and leukocyte recruitment to infection at an epithelial surface were studied during Escherichia coli-induced mastitis. One uninfected gland of each of eight midlactation cows was challenged with only 30 CFU of E. coli McDonald strain 487, a serum-resistant isolate from a cow with mastitis. Bacteria grew logarithmically during the first 10 to 12 h after challenge, reaching concentrations of more than 10(5) CFU/ml with no detectable host response during this time. An intense inflammatory reaction began approximately 12 h after the challenge and was characterized by a breakdown in the blood-milk permeability barrier followed by pyrexia and a pronounced leukocytic influx. Coincident with the onset of mammary inflammation was the appearance of neutrophil chemotactic activity in the milk from infected glands. Factors able to upregulate CD18 expression on peripheral blood neutrophils also appeared in milk at this time. The lack of appearance of chemotactic and CD18-upregulating activities until 12 h after challenge indicated that delays in neutrophil recruitment resulted from an initial lack of bacterial recognition and inflammatory mediator production. Production of complement fragment C5a, tumor necrosis factor, and interleukin-1 (IL-1) occurred earlier than production of IL-6 or IL-8. The early and intense production of C5a indicates that this chemoattractant may be more important than IL-8 during the initial recruitment and activation of neutrophils to a developing E. coli infection.
Shuster
D E
DE
Metabolic Diseases and Immunology Research Unit, National Animal Disease Center, USDA-Agricultural Research Service, Ames, Iowa 50010, USA. shusterd@pt.cyanamid.com
Kehrli
M E
ME
Rainard
P
P
Paape
M
M
D000818:Animals; D002417:Cattle; D002634:Chemotaxis, Leukocyte; D015936:Complement C5a / Q000502:physiology*; D016207:Cytokines / Q000502:physiology*; D004927:Escherichia coli Infections / Q000276:immunology*; D005260:Female; D018836:Inflammation Mediators / Q000502:physiology*; D016209:Interleukin-8 / Q000494:pharmacology; D008321:Mammary Glands, Animal / Q000382:microbiology*; D009504:Neutrophils / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D016207:Cytokines; D018836:Inflammation Mediators; D016209:Interleukin-8; D014409:Tumor Necrosis Factor-alpha; D015936:Complement C5a